The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

Abstract Background Sorafenib and transarterial chemoembolization (TACE) are recommended therapies for advanced hepatocellular carcinoma (HCC), but their combined efficacy remains unclear. Methods Between August 2004 and November 2014, 104 patients with BCLC stage B/C HCC were enrolled at the Affili...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Fei-Xiang Wu, Jie Chen, Tao Bai, Shao-Liang Zhu, Tian-Bo Yang, Lu-Nan Qi, Ling Zou, Zi-Hui Li, Jia-Zhou Ye, Le-Qun Li
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2017-09-01
Seri Bilgileri:	BMC Cancer
Konular:	Hepatocellular carcinoma Sorafenib Transarterial chemoembolization Portal vein tumor thrombus Adverse events
Online Erişim:	http://link.springer.com/article/10.1186/s12885-017-3545-5
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!